Andreas Lennartsson

Andreas Lennartsson has a master in Biotechnology from Lund University in Sweden. He did his PhD in Experimental hematology also at Lund University. After his PhD he contunied to the OMICS center at RIKEN in JAPAN for post-doc training in Piero Carninci's group. He carried out his second post-doc i Karl Ekwall's group at Karolinska Institute, where he is now leading a sub-group in Prof. Ekwall's laboratory.

His publications are as follows:
Gene regulation. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells Arner E, Daub Co, Vitting-seerup K, Andersson R, Lilje B, Drablos F, et al Science (New York, N.Y.) 2015;347(6225):1010 4.
Technical Advance: Transcription factor, promoter, and enhancer utilization in human myeloid cells Fantom Consortium, Joshi A, Pooley C, Freeman Tc, Lennartsson A, Babina M, et al JOURNAL OF LEUKOCYTE BIOLOGY 2015;97(5):985-995.
The roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemia Prasad P, Lennartsson A, Ekwall K BioMed research international 2015;2015():347571.
Transcription-coupled recruitment of human CHD1 and CHD2 influences chromatin accessibility and histone H3 and H3.3 occupancy at active chromatin regions Siggens L, Cordeddu L, Ronnerblad M, Lennartsson A, Ekwall K Epigenetics & chromatin 2015;8(1):4.